Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 1Life Healthcare IncONEM · Entity 116460 | Director | July 15, 2021 | July 19, 2021 |
| Infleqtion, Inc.INFQ · Entity 4264 | Director | May 27, 2026 | May 30, 2026 |
| Seer, Inc.SEER · Entity 6717 | Director | June 17, 2021 | June 22, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
1Life Healthcare Inc
Report date July 15, 2021 · Filed July 19, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 264 |
Reported balance
After 2021-07-15 transaction · row 1
1 source rowRow 1 · 2021-07-15 · Grant · Acquired 264 · Balance 264 F1: Represents restricted stock units granted to the reporting person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vested immediately on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units granted to the reporting person pursuant to the Issuer's 2020 Equity Incentive Plan. The restricted stock units vested immediately on the date of grant.
Infleqtion, Inc.
Report date May 27, 2026 · Filed May 30, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 2,655,270 |
Reported balance
After 2026-05-27 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-05-27 · Other · Disposed 460,072 · Balance 2,655,270 F1: Maverick Advisors Fund, L.P. ("Maverick Advisors Fund") distributed these shares to its limited partners pro rata for no consideration (the "MAF Distribution"). F7: Held directly by Maverick Advisors Fund. Maverick Capital Ventures, LLC ("Maverick Ventures") is the general partner of Maverick Advisors Fund. The Reporting Person is a managing partner of Maverick Ventures. F11: The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 1,896,709 |
Reported balance
After 2026-05-27 transaction · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · 2026-05-27 · Sale · Disposed 758,561 · Balance 1,896,709 F2: These shares were sold by Maverick Advisors Fund as part of the MAF Distribution, and the proceeds of such sales were distributed to certain limited partners of Maverick Advisors Fund. F6: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.67 to $15.66 inclusive. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range. F7: Held directly by Maverick Advisors Fund. Maverick Capital Ventures, LLC ("Maverick Ventures") is the general partner of Maverick Advisors Fund. The Reporting Person is a managing partner of Maverick Ventures. F11: The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 1,564,070 |
Reported balance
After 2026-05-27 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2026-05-27 · Sale · Disposed 332,639 · Balance 1,564,070 F2: These shares were sold by Maverick Advisors Fund as part of the MAF Distribution, and the proceeds of such sales were distributed to certain limited partners of Maverick Advisors Fund. F12: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.67 to $16.38 inclusive. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range. F7: Held directly by Maverick Advisors Fund. Maverick Capital Ventures, LLC ("Maverick Ventures") is the general partner of Maverick Advisors Fund. The Reporting Person is a managing partner of Maverick Ventures. F11: The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 4,410,403 |
Reported balance
After 2026-05-27 transaction · row 4
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 4 · 2026-05-27 · Other · Disposed 508,549 · Balance 4,410,403 F3: Maverick Ventures Investment Fund, L.P. ("Maverick Ventures Fund") distributed these shares to its limited partners pro rata for no consideration (the "MVIF Distribution"). F8: Held directly by Maverick Ventures Fund. Maverick Ventures is the general partner of Maverick Ventures Fund. F11: The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 3,033,687 |
Reported balance
After 2026-05-27 transaction · row 5
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 5 · 2026-05-27 · Sale · Disposed 1,376,716 · Balance 3,033,687 F4: These shares were sold Maverick Ventures Fund as part of the MVIF Distribution, and the proceeds of such sales were distributed to certain limited partners of Maverick Ventures Fund. F6: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.67 to $15.66 inclusive. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range. F8: Held directly by Maverick Ventures Fund. Maverick Ventures is the general partner of Maverick Ventures Fund. F11: The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 2,429,980 |
Reported balance
After 2026-05-27 transaction · row 6
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 6 · 2026-05-27 · Sale · Disposed 603,707 · Balance 2,429,980 F4: These shares were sold Maverick Ventures Fund as part of the MVIF Distribution, and the proceeds of such sales were distributed to certain limited partners of Maverick Ventures Fund. F12: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.67 to $16.38 inclusive. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range. F8: Held directly by Maverick Ventures Fund. Maverick Ventures is the general partner of Maverick Ventures Fund. F11: The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 349,693 |
Reported balance
After 2026-05-27 transaction · row 7
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 7 · 2026-05-27 · Other · Acquired 349,693 · Balance 349,693 F5: Received for no consideration in the pro rata distributions effected by Maverick Advisors Fund and Maverick Ventures Fund. F9: Held directly by Maverick Ventures. F11: The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 83,773 |
Reported balance
After 2026-05-27 transaction · row 8
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 8 · 2026-05-27 · Other · Acquired 83,773 · Balance 83,773 F5: Received for no consideration in the pro rata distributions effected by Maverick Advisors Fund and Maverick Ventures Fund. F10: Held directly by family estate planning entities controlled by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Maverick Advisors Fund, L.P. ("Maverick Advisors Fund") distributed these shares to its limited partners pro rata for no consideration (the "MAF Distribution").
F2: These shares were sold by Maverick Advisors Fund as part of the MAF Distribution, and the proceeds of such sales were distributed to certain limited partners of Maverick Advisors Fund.
F3: Maverick Ventures Investment Fund, L.P. ("Maverick Ventures Fund") distributed these shares to its limited partners pro rata for no consideration (the "MVIF Distribution").
F4: These shares were sold Maverick Ventures Fund as part of the MVIF Distribution, and the proceeds of such sales were distributed to certain limited partners of Maverick Ventures Fund.
F5: Received for no consideration in the pro rata distributions effected by Maverick Advisors Fund and Maverick Ventures Fund.
F6: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.67 to $15.66 inclusive. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range.
F7: Held directly by Maverick Advisors Fund. Maverick Capital Ventures, LLC ("Maverick Ventures") is the general partner of Maverick Advisors Fund. The Reporting Person is a managing partner of Maverick Ventures.
F8: Held directly by Maverick Ventures Fund. Maverick Ventures is the general partner of Maverick Ventures Fund.
F9: Held directly by Maverick Ventures.
F10: Held directly by family estate planning entities controlled by the Reporting Person.
F11: The Reporting Person disclaims, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, beneficial ownership of these securities, except to the extent of his pecuniary interest therein.
F12: The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.67 to $16.38 inclusive. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range.
Seer, Inc.
Report date June 17, 2021 · Filed June 22, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.74 · Expires 2031-06-17 | Direct | 15,000 |
Reported balance
After 2021-06-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-06-17 · Grant · Acquired 15,000 · Balance 15,000 F1: Shares subject to the option vest on the earlier of (i) June 17, 2022 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. F2: The reporting person is a Managing Partner of Maverick Capital Ventures, LLC (Maverick Ventures), the general partner of Maverick Ventures Investment Fund, L.P. and Maverick Advisors Fund, L.P. The reporting person is deemed to hold the reported stock option for the benefit of the Maverick Ventures, which entity is entitled to the shares of Class A Common Stock issued upon exercise. Maverick Ventures may be deemed the indirect beneficial owner of this stock option, and the reporting person may be deemed the indirect beneficial owner of the option through his indirect interest in Maverick Ventures. The reporting person disclaims beneficial ownership of the stock option except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares subject to the option vest on the earlier of (i) June 17, 2022 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders.
F2: The reporting person is a Managing Partner of Maverick Capital Ventures, LLC (Maverick Ventures), the general partner of Maverick Ventures Investment Fund, L.P. and Maverick Advisors Fund, L.P. The reporting person is deemed to hold the reported stock option for the benefit of the Maverick Ventures, which entity is entitled to the shares of Class A Common Stock issued upon exercise. Maverick Ventures may be deemed the indirect beneficial owner of this stock option, and the reporting person may be deemed the indirect beneficial owner of the option through his indirect interest in Maverick Ventures. The reporting person disclaims beneficial ownership of the stock option except to the extent of his pecuniary interest therein.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CASTLIGHT HEALTH, INC.
Report date February 17, 2022 · Filed February 18, 2022
Section 16 reporting ended · disclosed 2022-02-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 1
1 source rowRow 1 · 2022-02-17 · Disposition to issuer · Disposed 405,184 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.00 · Expires 2024-03-12 | Direct | 0 |
Reported balance
After 2022-02-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-02-17 · Disposition to issuer · Disposed 25,000 · Balance 0 F3: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time. F2: The option is fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 4, 2022, by and among the Issuer, Vera Whole Health, Inc. ("Vera Health"), and Carbon Merger Sub, Inc. (the "Merger Sub"), the Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Vera Health, effective as of February 17, 2022 (the "Effective Time"). Pursuant to the Merger Agreement, each share of the Issuer's Class A common stock and Class B common stock was exchanged for $2.05 in cash (the "Merger Consideration") at the Effective Time.
F2: The option is fully vested and exercisable.
F3: The option exercise price is equal to or exceeds the Merger Consideration and therefore the option was automatically cancelled without consideration immediately prior to the Effective Time.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 08, 2020 Filed Dec 11, 2020 02:54 UTC | Seer, Inc. SEER · Entity 6717 | ConversionSeries B Convertible Preferred Stock · Derivative | 700,762 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-017381 · wf-form4_160765528377568.xml · derivative · entry 9 SINGER DAVID B · CIK 0001240366 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 700,762 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F2 · price: Each share of Series B Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F2 · derivative.exercise_date: Each share of Series B Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F2 · derivative.expiration_date: Each share of Series B Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F7 · ownership.nature: The reported shares are held of record by Maverick Advisors Fund, L.P. ("Maverick Advisors"). Maverick Ventures is the general partner of Maverick Advisors. As a Managing Partner of Maverick Ventures, the reporting person shares voting and dispositive power with respect to the shares held by Maverick Advisors. The reporting person disclaims beneficial ownership of the reported securities of the Issuer held of record by Maverick Advisors except to the extent of his pecuniary interest therein. Read SEC document |
| December 08, 2020 Filed Dec 11, 2020 02:54 UTC | Seer, Inc. SEER · Entity 6717 | ConversionSeries A Convertible Preferred Stock · Derivative | 777,593 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-017381 · wf-form4_160765528377568.xml · derivative · entry 8 SINGER DAVID B · CIK 0001240366 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 777,593 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F1 · price: Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F7 · ownership.nature: The reported shares are held of record by Maverick Advisors Fund, L.P. ("Maverick Advisors"). Maverick Ventures is the general partner of Maverick Advisors. As a Managing Partner of Maverick Ventures, the reporting person shares voting and dispositive power with respect to the shares held by Maverick Advisors. The reporting person disclaims beneficial ownership of the reported securities of the Issuer held of record by Maverick Advisors except to the extent of his pecuniary interest therein. Read SEC document |
| December 08, 2020 Filed Dec 11, 2020 02:54 UTC | Seer, Inc. SEER · Entity 6717 | ConversionSeries D-1 Convertible Preferred Stock · Derivative | 242,204 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-017381 · wf-form4_160765528377568.xml · derivative · entry 7 SINGER DAVID B · CIK 0001240366 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 242,204 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each share of Series D-1 Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F5 · price: Each share of Series D-1 Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F5 · derivative.exercise_date: Each share of Series D-1 Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F5 · derivative.expiration_date: Each share of Series D-1 Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F6 · ownership.nature: The reported shares are held of record by Maverick Ventures Investment Fund, L.P. ("Maverick Ventures Fund"). Maverick Capital Ventures, LLC (Maverick Ventures) is the general partner of Maverick Ventures Fund. As a Managing Partner of Maverick Ventures, the reporting person shares voting and dispositive power with respect to the shares held by Maverick Ventures Fund. The reporting person disclaims beneficial ownership of the reported securities of the Issuer held of record by Maverick Ventures Fund except to the extent of his pecuniary interest therein. Read SEC document |
| December 08, 2020 Filed Dec 11, 2020 02:54 UTC | Seer, Inc. SEER · Entity 6717 | ConversionSeries D Convertible Preferred Stock · Derivative | 326,269 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-017381 · wf-form4_160765528377568.xml · derivative · entry 6 SINGER DAVID B · CIK 0001240366 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 326,269 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each share of Series D Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F4 · price: Each share of Series D Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F4 · derivative.exercise_date: Each share of Series D Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F4 · derivative.expiration_date: Each share of Series D Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F6 · ownership.nature: The reported shares are held of record by Maverick Ventures Investment Fund, L.P. ("Maverick Ventures Fund"). Maverick Capital Ventures, LLC (Maverick Ventures) is the general partner of Maverick Ventures Fund. As a Managing Partner of Maverick Ventures, the reporting person shares voting and dispositive power with respect to the shares held by Maverick Ventures Fund. The reporting person disclaims beneficial ownership of the reported securities of the Issuer held of record by Maverick Ventures Fund except to the extent of his pecuniary interest therein. Read SEC document |
| December 08, 2020 Filed Dec 11, 2020 02:54 UTC | Seer, Inc. SEER · Entity 6717 | ConversionSeries C Convertible Preferred Stock · Derivative | 265,434 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-017381 · wf-form4_160765528377568.xml · derivative · entry 5 SINGER DAVID B · CIK 0001240366 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 265,434 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series C Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F3 · price: Each share of Series C Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F3 · derivative.exercise_date: Each share of Series C Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F3 · derivative.expiration_date: Each share of Series C Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F6 · ownership.nature: The reported shares are held of record by Maverick Ventures Investment Fund, L.P. ("Maverick Ventures Fund"). Maverick Capital Ventures, LLC (Maverick Ventures) is the general partner of Maverick Ventures Fund. As a Managing Partner of Maverick Ventures, the reporting person shares voting and dispositive power with respect to the shares held by Maverick Ventures Fund. The reporting person disclaims beneficial ownership of the reported securities of the Issuer held of record by Maverick Ventures Fund except to the extent of his pecuniary interest therein. Read SEC document |
| December 08, 2020 Filed Dec 11, 2020 02:54 UTC | Seer, Inc. SEER · Entity 6717 | ConversionSeries B Convertible Preferred Stock · Derivative | 1,275,928 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-017381 · wf-form4_160765528377568.xml · derivative · entry 4 SINGER DAVID B · CIK 0001240366 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 1,275,928 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each share of Series B Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F2 · price: Each share of Series B Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F2 · derivative.exercise_date: Each share of Series B Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F2 · derivative.expiration_date: Each share of Series B Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F6 · ownership.nature: The reported shares are held of record by Maverick Ventures Investment Fund, L.P. ("Maverick Ventures Fund"). Maverick Capital Ventures, LLC (Maverick Ventures) is the general partner of Maverick Ventures Fund. As a Managing Partner of Maverick Ventures, the reporting person shares voting and dispositive power with respect to the shares held by Maverick Ventures Fund. The reporting person disclaims beneficial ownership of the reported securities of the Issuer held of record by Maverick Ventures Fund except to the extent of his pecuniary interest therein. Read SEC document |
| December 08, 2020 Filed Dec 11, 2020 02:54 UTC | Seer, Inc. SEER · Entity 6717 | ConversionSeries A Convertible Preferred Stock · Derivative | 1,280,724 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-017381 · wf-form4_160765528377568.xml · derivative · entry 3 SINGER DAVID B · CIK 0001240366 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 1,280,724 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F1 · price: Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F1 · derivative.exercise_date: Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F1 · derivative.expiration_date: Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F6 · ownership.nature: The reported shares are held of record by Maverick Ventures Investment Fund, L.P. ("Maverick Ventures Fund"). Maverick Capital Ventures, LLC (Maverick Ventures) is the general partner of Maverick Ventures Fund. As a Managing Partner of Maverick Ventures, the reporting person shares voting and dispositive power with respect to the shares held by Maverick Ventures Fund. The reporting person disclaims beneficial ownership of the reported securities of the Issuer held of record by Maverick Ventures Fund except to the extent of his pecuniary interest therein. Read SEC document |
| December 08, 2020 Filed Dec 11, 2020 02:54 UTC | Seer, Inc. SEER · Entity 6717 | ConversionClass A Common Stock | 1,934,954 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-017381 · wf-form4_160765528377568.xml · nonDerivative · entry 2 SINGER DAVID B · CIK 0001240366 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,934,954 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F2 · price: Each share of Series B Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F3 · price: Each share of Series C Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F4 · price: Each share of Series D Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F5 · price: Each share of Series D-1 Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F7 · ownership.nature: The reported shares are held of record by Maverick Advisors Fund, L.P. ("Maverick Advisors"). Maverick Ventures is the general partner of Maverick Advisors. As a Managing Partner of Maverick Ventures, the reporting person shares voting and dispositive power with respect to the shares held by Maverick Advisors. The reporting person disclaims beneficial ownership of the reported securities of the Issuer held of record by Maverick Advisors except to the extent of his pecuniary interest therein. Read SEC document |
| December 08, 2020 Filed Dec 11, 2020 02:54 UTC | Seer, Inc. SEER · Entity 6717 | ConversionClass A Common Stock | 3,390,559 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-20-017381 · wf-form4_160765528377568.xml · nonDerivative · entry 1 SINGER DAVID B · CIK 0001240366 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 3,390,559 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F2 · price: Each share of Series B Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F3 · price: Each share of Series C Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F4 · price: Each share of Series D Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F5 · price: Each share of Series D-1 Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date. F6 · ownership.nature: The reported shares are held of record by Maverick Ventures Investment Fund, L.P. ("Maverick Ventures Fund"). Maverick Capital Ventures, LLC (Maverick Ventures) is the general partner of Maverick Ventures Fund. As a Managing Partner of Maverick Ventures, the reporting person shares voting and dispositive power with respect to the shares held by Maverick Ventures Fund. The reporting person disclaims beneficial ownership of the reported securities of the Issuer held of record by Maverick Ventures Fund except to the extent of his pecuniary interest therein. Read SEC document |
| December 03, 2020 Filed Dec 12, 2020 02:28 UTC | Seer, Inc. SEER · Entity 6717 | GrantStock Option (right to buy) · Derivative | 37,383 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001628280-20-017434 · wf-form4_160774010079844.xml · derivative · entry 1 SINGER DAVID B · CIK 0001240366 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,383 Underlying: Class A Common Stock · 37,383 shares Expires 2020-12-03 F1 · derivative.exercise_date: Shares subject to the option vest in 36 equal monthly installments beginning on January 3, 2021. F2 · ownership.direct: The reporting person is a Managing Partner of Maverick Capital Ventures, LLC (Maverick Ventures), the general partner of Maverick Ventures Investment Fund, L.P. and Maverick Advisors Fund, L.P. The reporting person is deemed to hold the reported stock option for the benefit of the Maverick Ventures, which entity is entitled to the shares of Class A Common Stock issued upon exercise. Maverick Ventures may be deemed the indirect beneficial owner of this stock option, and the reporting person may be deemed the indirect beneficial owner of the option through his indirect interest in Maverick Ventures. The reporting person disclaims beneficial ownership of the stock option except to the extent of his pecuniary interest therein. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 18:54 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | GrantStock Option (Right to Buy) · Derivative | 676 | $0.00 Strike: $30.48 | $0.00 |
DisclosureSEC source: 0001562180-20-006390 · primarydocument.xml · derivative · entry 1 SINGER DAVID B · CIK 0001240366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 676 Underlying: Common Stock · 676 shares Expires 2030-10-14 Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 19:07 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | GrantStock Option (Right to Buy) · Derivative | 498 | $0.00 Strike: $40.55 | $0.00 |
DisclosureSEC source: 0001562180-20-005179 · primarydocument.xml · derivative · entry 1 SINGER DAVID B · CIK 0001240366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 498 Underlying: Common Stock · 498 shares Expires 2030-07-14 Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 17:50 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantClass B Common Stock | 180,645 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-034759 · doc4.xml · nonDerivative · entry 1 SINGER DAVID B · CIK 0001240366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,477 F1 · shares: Represents an award of restricted stock units ("RSUs"). 25% of the RSUs will vest on August 16, 2020, and the remaining 75% of the RSUs will vest in 3 equal quarterly installments thereafter beginning on November 16, 2020. Each RSU represents a contingent right to receive one share of the Issuer's Class B common stock upon settlement for no consideration. Read SEC document |
| May 14, 2020 Filed May 18, 2020 17:53 UTC | 1Life Healthcare Inc ONEM · Entity 116460 | GrantStock Option (Right to Buy) · Derivative | 5,294 | $0.00 Strike: $29.00 | $0.00 |
DisclosureSEC source: 0001209191-20-030197 · doc4.xml · derivative · entry 1 SINGER DAVID B · CIK 0001240366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,294 Underlying: Common Stock · 5,294 shares Expires 2030-05-13 F1 · derivative.exercise_date: The shares subject to the option will vest on the earlier of (i) the date of the Issuer's next annual meeting of stockholders (or the date immediately prior to the next annual meeting of stockholders if the Reporting Person's service as a director ends at such meeting due to the director's failure to be re-elected or the director not standing for re-election); or (ii) the one-year anniversary measured from the date of grant. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 18:58 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantClass B Common Stock | 44,164 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013100 · doc1.xml · nonDerivative · entry 1 SINGER DAVID B · CIK 0001240366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,832 F1 · shares: Represents an award of restricted stock units ("RSUs"). 25% of the RSUs will vest on August 16, 2019, and the remaining 75% of the RSUs will vest in 3 equal quarterly installments thereafter beginning on November 16, 2019. Each RSU represents a contingent right to receive one share of the Issuer's Class B common stock upon settlement for no consideration. F2 · ownership.direct: These RSUs are held by David B. Singer for the benefit of entities managed by Maverick Capital, Ltd. Mr. Singer is an employee of an affiliate of Maverick Capital, Ltd. Read SEC document |
| June 20, 2018 Filed Jun 22, 2018 17:39 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantClass B Common Stock | 32,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-029641 · doc1.xml · nonDerivative · entry 1 SINGER DAVID B · CIK 0001240366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,668 F1 · shares: Represents an award of restricted stock units ("RSUs"). 25% of the RSUs will vest on August 16, 2018, and the remaining 75% of the RSUs will vest in 3 equal quarterly installments thereafter beginning on November 16, 2018. Each RSU represents a contingent right to receive one share of the Issuer's Class B common stock upon settlement for no consideration. F2 · ownership.direct: These RSUs are held by David B. Singer for the benefit of entities managed by Maverick Capital, Ltd. Mr. Singer is an employee of an affiliate of Maverick Capital, Ltd. Read SEC document |
| June 22, 2017 Filed Jun 26, 2017 19:27 UTC | CASTLIGHT HEALTH, INC. CSLT · Entity 130187 | GrantClass B Common Stock | 33,735 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-026124 · doc1.xml · nonDerivative · entry 1 SINGER DAVID B · CIK 0001240366 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,485 F1 · shares: Represents an award of restricted stock units ("RSUs"). 25% of the RSUs will vest on September 22, 2017 and an additional 25% will vest on each quarterly anniversary thereafter. Each RSU represents a contingent right to receive one share of the Issuer's Class B common stock upon settlement for no consideration. F2 · ownership.direct: These RSUs are held by David B. Singer for the benefit of entities managed by Maverick Capital, Ltd. Mr. Singer is an employee of an affiliate of Maverick Capital, Ltd. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.